Bluejay Diagnostics Inc
NASDAQ:BJDX
Bluejay Diagnostics Inc
NASDAQ:BJDX
Price:
2.06
USD
1.48%
Market Cap:
$1.5m
Income Statement
Earnings Waterfall
Bluejay Diagnostics Inc
Bluejay Diagnostics Inc
Income Statement
Bluejay Diagnostics Inc
Bluejay Diagnostics Inc
Currency: USD
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(3)
|
(4)
|
(6)
|
(8)
|
(9)
|
(10)
|
(11)
|
(10)
|
(10)
|
(10)
|
(9)
|
(8)
|
(7)
|
(7)
|
(7)
|
(7)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
|
| Research & Development |
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Operating Income |
(3)
N/A
|
(4)
-36%
|
(6)
-45%
|
(8)
-29%
|
(9)
-13%
|
(10)
-9%
|
(11)
-9%
|
(10)
+6%
|
(10)
+1%
|
(10)
+2%
|
(9)
+10%
|
(8)
+11%
|
(7)
+11%
|
(7)
+8%
|
(7)
-1%
|
(7)
-4%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(3)
N/A
|
(5)
-34%
|
(7)
-42%
|
(8)
-27%
|
(9)
-11%
|
(10)
-6%
|
(11)
-9%
|
(10)
+6%
|
(10)
+1%
|
(10)
+2%
|
(9)
+3%
|
(9)
+9%
|
(8)
+10%
|
(7)
+6%
|
(7)
+7%
|
(7)
-2%
|
|
| Net Income | |||||||||||||||||
| Income from Continuing Operations |
(3)
|
(5)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(10)
|
(10)
|
(10)
|
(9)
|
(9)
|
(8)
|
(7)
|
(7)
|
(7)
|
|
| Net Income (Common) |
(3)
N/A
|
(5)
-34%
|
(7)
-42%
|
(8)
-27%
|
(9)
-11%
|
(10)
-6%
|
(11)
-9%
|
(10)
+6%
|
(10)
+1%
|
(10)
+2%
|
(9)
+3%
|
(9)
+9%
|
(21)
-144%
|
(20)
+2%
|
(20)
+3%
|
(20)
-1%
|
|
| EPS (Diluted) |
-5 539.68
N/A
|
-7 396.82
-34%
|
-10 476.19
-42%
|
-13 285.71
-27%
|
-14 761.9
-11%
|
-15 359.37
-4%
|
-16 718.74
-9%
|
-14 550.72
+13%
|
-14 425.92
+1%
|
-6 626.67
+54%
|
-3 887.02
+41%
|
-179.75
+95%
|
-456.75
-154%
|
-147.84
+68%
|
-57.55
+61%
|
-50.98
+11%
|
|
Switch to:
Switch to:
See Also
Discover More
